Extractables & Leachables in Pharma: Navigating Evolving Regulations and Toxicological Challenges

This webinar on demand aims to provide a comprehensive overview of Extractables and Leachables (E&L) in pharmaceutical products, highlighting regulatory complexities, toxicological challenges, and practical approaches to study design and risk assessment across the product lifecycle.

Let's decode E&L risks and safeguard product safety and regulatory compliance!

circles-1
Calander_icon
On demand
Clock_icon
1h
Tag_icon
Pharma
language_icon
English

About the webinar on demand

Extractables and Leachables (E&L) are critical impurities that can migrate from pharmaceutical packaging into the drug product, potentially compromising patient safety. This webinar offers a foundational understanding of what E&L are, why they matter, how E&L can impact drug safety and stability, and how they are assessed in pharmaceutical manufacturing.

 

Participants will gain insights into the current, often fragmented, regulatory landscape and learn about evolving global guidelines that influence E&L evaluations. A special focus will be placed on the toxicological assessment of E&L, including their classification, integration into risk assessment strategies, and their role across the product lifecycle. The session will also explore the practicalities of designing and executing E&L studies, supported by real-world examples. 

 

Whether you're new to the topic or looking to deepen your expertise, this webinar provides the critical knowledge needed to navigate the complex regulatory and scientific terrain surrounding E&L.

webinar - riesgo de las nitrosaminas - QbD Group

What you'll learn

  • The fundamentals of Extractables and Leachables (E&L), including definitions, sources, and their impact on drug safety.
  • Current regulatory framework, including gaps, challenges, and relevant global guidelines.
  • Insight on toxicological risk assessment strategies for E&L throughout the pharmaceutical product lifecycle.
  • Best practices for designing and executing E&L studies, from planning to reporting.
  • Review real-world study examples to understand practical applications and common pitfalls in E&L evaluations.

Speakers

Meet our expert speakers who will share valuable insights and practical knowledge drawn from extensive industry experience.

Natalia Herrera

Global Toxicology Liason

Natalia holds a PhD in Pharmacy from the University of Medical Sciences of Costa Rica and a Master's degree in Drug Research, Development and Innovation from the University of Navarra. With a strong background in business development, Natalia previously worked in a preclinical CRO, where she excelled in driving growth and establishing strategic alliances. Her career also includes outstanding contributions as Medical Sales Representative in different companies, such as Abbott. In addition, Natalia has valuable experience in quality assurance from her time at Pfizer and other pharmaceutical manufacturing sites, ensuring compliance with industry standards.

 

Javier López

Consultant Toxicology
Javier holds a degree in Chemistry and a Master’s in Drug Discovery. He began his career in public research, focusing on the synthesis and structural characterization of cannabinoids, gaining valuable experience in organic chemistry and analytical techniques, moving later to the pharmaceutical industry focusing method validation and risk assessment of extractables and leachables (E&L) and elemental impurities in accordance with ICH Q3D guidelines.

 

 

Webinar Page Icon - Watch Webinar

Watch here

 Submit your contact details to register to this webinar on demand. Don’t miss out on valuable insights and actionable strategies from our industry experts.

Get in touch_QbD group-1

Upcoming webinars

webinar-image

From R&D to market IP and regulatory strategy across the product life cycle

Join this Biovia x Gevers x QbD Group webinar to explore product life cycle strategies, focusing on R&D, regulatory alignment, and Quality by Design insights for life sciences professionals.
Medical Devices
Read more
webinar-image

Nitrosamine Risk Assessment: Adapting to the Latest Regulatory Expectations

Manage the risk of nitrosamines in the pharmaceutical industry. Join our webinar and learn about regulation and risk analysis from experts.
Pharma & Biotech
Read more
webinar-image

From Strategy to First-in-Human: A Practical Roadmap for Biotech Development

Join our webinar to learn how to navigate nitrosamine risks and streamline your biotech development from early planning to first-in-human trials. Register now for expert insights.
Pharma & Biotech
Read more
webinar-image

AI in Life Sciences

Join our webinar with delaware on implementing compliant AI in life sciences. Learn best practices and avoid pitfalls in GxP environments from industry experts. Register now.
Software Solutions & Services
Read more

We share the latest news

Staying on top of the latest in the life science industry can be a daunting task. This newsletter will keep you up-to-date with the latest news, blogs and webinars so you can keep ahead of the curve.
Circles-banner-short